Literature DB >> 14559983

Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors.

Gary M K Tse1, Philip C W Lui, Richard A Scolyer, Thomas C Putti, Fred Y L Kung, Bonita K B Law, Tai-Shing Lau, C Soon Lee.   

Abstract

We examined 186 phyllodes tumors (106 benign, 51 borderline, 29 malignant) for angiogenesis by assessing stromal microvessel density by the hot spot method and assessing p53 protein expression; we correlated these factors with stromal cellularity, margin status, nuclear pleomorphism, mitosis, and stromal overgrowth. Increased degree of malignancy in phyllodes tumors is associated with increased patient age and tumor size. Microvessel density and p53 protein expression also showed a similar increase with malignancy. Using a logistic regression model, microvessel density was shown to be useful in predicting malignancy in phyllodes tumors, independent of key criteria of stromal overgrowth, nuclear pleomorphism, and mitosis. Microvessel density showed correlation with stromal cellularity and margin status, suggesting an interrelationship between these parameters. P53 protein expression showed a positive correlation with microvessel density, suggesting possible overlap in the underlying mechanism of these two factors in the pathogenesis of phyllodes tumors. The numbers of recurrences and metastases are small in our series, and no significant difference was demonstrated in microvessel density and p53 protein expression compared with the primary. We conclude that microvessel density and p53 are useful as independent criteria in evaluating malignancy in phyllodes tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559983     DOI: 10.1097/01.MP.0000089907.67419.42

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Major response to sunitinib (Sutene) in metastatic malignant phyllodes tumor of breast.

Authors:  In Hae Park; Youngmee Kwon; Eun-A Kim; Keun Seok Lee; Jungsil Ro
Journal:  Invest New Drugs       Date:  2008-11-11       Impact factor: 3.850

2.  Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.

Authors:  G M K Tse; A K H Tsang; T C Putti; R A Scolyer; P C W Lui; B K B Law; R Z Karim; C S Lee
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

3.  Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.

Authors:  Gary M Tse; Benjaporn Chaiwun; Kin-Mang Lau; Richard Scolyer; C Soon Lee; Rooshdiya Z Karim; Thomas C Putti; Bonita K Law; Philip C Lui; Puay Hoon Tan
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

4.  Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.

Authors:  G M K Tse; F C Wong; A K H Tsang; C S Lee; P C W Lui; A W I Lo; B K B Law; R A Scolyer; R Z Karim; T C Putti
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

5.  Three assays show differences in binding of wild-type and mutant p53 to unique gene sequences.

Authors:  Uma Chandrachud; Susannah Gal
Journal:  Technol Cancer Res Treat       Date:  2009-12

6.  Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.

Authors:  Zoran Gatalica; Semir Vranic; Anatole Ghazalpour; Joanne Xiu; Idris Tolgay Ocal; John McGill; Ryan P Bender; Erin Discianno; Aaron Schlum; Souzan Sanati; Juan Palazzo; Sandeep Reddy; Barbara Pockaj
Journal:  Oncotarget       Date:  2016-01-12

7.  Malignant phyllodes tumor metastasized to the right ventricle: a case report.

Authors:  Fumi Yoshidaya; Naoki Hayashi; Katsuhito Takahashi; Koyu Suzuki; Futoshi Akiyama; Mitsutomi Ishiyama; Yuko Takahashi; Atsushi Yoshida; Hiroshi Yagata; Seigo Nakamura; Hiroko Tsunoda; Hideko Yamauchi
Journal:  Surg Case Rep       Date:  2015-12-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.